169 related articles for article (PubMed ID: 21464837)
1. Structural inferences for Cholera toxin mutations in Vibrio cholerae.
Shamini G; Ravichandran M; Sinnott JT; Somboonwit C; Sidhu HS; Shapshak P; Kangueane P
Bioinformation; 2011 Mar; 6(1):1-9. PubMed ID: 21464837
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the possible role of ctxB7 allele on higher production of cholera toxin by Haitian variant Vibrio cholerae O1.
Naha A; Mandal RS; Samanta P; Saha RN; Shaw S; Ghosh A; Chatterjee NS; Dutta P; Okamoto K; Dutta S; Mukhopadhyay AK
PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008128. PubMed ID: 32236098
[TBL] [Abstract][Full Text] [Related]
3. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates.
Singh DV; Matte MH; Matte GR; Jiang S; Sabeena F; Shukla BN; Sanyal SC; Huq A; Colwell RR
Appl Environ Microbiol; 2001 Feb; 67(2):910-21. PubMed ID: 11157262
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a Nonagglutinating Toxigenic Vibrio cholerae Isolate.
Gladney LM; Griswold T; Turnsek M; Im MS; Parsons MMB; Katz LS; Tarr CL; Lee CC
Microbiol Spectr; 2023 Jun; 11(3):e0018223. PubMed ID: 37195209
[TBL] [Abstract][Full Text] [Related]
6. [Serotyping and genotypic characteristic of Vibrio cholerae non-O1/non-O139 serogroups isolated from water of surface basins and sewages of Rostov-on-Don city in 2003 - 2008].
Kruglikov VD; Lomov IuM; Avdeeva EP; Monakhova EV; Ezhova MI; Arkhangel'skaia IV; Shestialtynova IS; Tsedova EG; Shalu OA; Uskova NN; Grigorenko LV
Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):3-8. PubMed ID: 20468095
[TBL] [Abstract][Full Text] [Related]
7. [Distribution of serogroups of Vibrio cholerae non-O1 non-O139 with specific reference to their ability to produce cholera toxin, and addition of novel serogroups].
Yamai S; Okitsu T; Shimada T; Katsube Y
Kansenshogaku Zasshi; 1997 Oct; 71(10):1037-45. PubMed ID: 9394556
[TBL] [Abstract][Full Text] [Related]
8. Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand.
Siriphap A; Leekitcharoenphon P; Kaas RS; Theethakaew C; Aarestrup FM; Sutheinkul O; Hendriksen RS
PLoS One; 2017; 12(1):e0169324. PubMed ID: 28103259
[TBL] [Abstract][Full Text] [Related]
9. Cholera Toxin Encapsulated within Several
Rasti ES; Brown AC
Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30959895
[TBL] [Abstract][Full Text] [Related]
10. Vibrio pathogenicity island and cholera toxin genetic element-associated virulence genes and their expression in non-O1 non-O139 strains of Vibrio cholerae.
Sarkar A; Nandy RK; Nair GB; Ghose AC
Infect Immun; 2002 Aug; 70(8):4735-42. PubMed ID: 12117994
[TBL] [Abstract][Full Text] [Related]
11. Temporal-Spatial Distribution of Vibrio cholerae in Cuba: July 1997-December 2019.
Fernández-Abreu A; Bravo-Fariñas L; Águila-Sánchez A; Cruz-Infante Y; Falcón-Márquez R; Toledo-Romaní ME; León-Venero MLÁ; Hernández-Martínez JL; Baldoquín-Rodríguez W; Germán-Almeida ÁM
MEDICC Rev; 2022 Oct; 24(3-4):24-29. PubMed ID: 36417331
[TBL] [Abstract][Full Text] [Related]
12. Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit.
Rhie GE; Jung HM; Kim BS; Mekalanos JJ
Vaccine; 2008 Oct; 26(43):5443-8. PubMed ID: 18582519
[TBL] [Abstract][Full Text] [Related]
13. Genetic and mutational analysis of virulence traits and their modulation in an environmental toxigenic
Biswas Q; Purohit A; Kumar A; Rakshit D; Maiti D; Das B; Bhadra RK
Microbiology (Reading); 2022 Feb; 168(2):. PubMed ID: 35113781
[No Abstract] [Full Text] [Related]
14. ToxR regulates virulence gene expression in non-O1 strains of Vibrio cholerae that cause epidemic cholera.
Waldor MK; Mekalanos JJ
Infect Immun; 1994 Jan; 62(1):72-8. PubMed ID: 7903285
[TBL] [Abstract][Full Text] [Related]
15. Molecular subtyping of toxigenic Vibrio cholerae O139 causing epidemic cholera in India and Bangladesh, 1992-1993.
Popovic T; Fields PI; Olsvik O; Wells JG; Evins GM; Cameron DN; Farmer JJ; Bopp CA; Wachsmuth K; Sack RB
J Infect Dis; 1995 Jan; 171(1):122-7. PubMed ID: 7528249
[TBL] [Abstract][Full Text] [Related]
16. A fluorescent peptide substrate for measuring the ADP-ribosylation activity of the cholera toxin A-subunit.
Yuen CT; Rijpkema S
Hum Vaccin; 2006; 2(5):195-9. PubMed ID: 17035737
[TBL] [Abstract][Full Text] [Related]
17. Distribution and virulence of Vibrio cholerae belonging to serogroups other than O1 and O139: a nationwide survey.
Mukhopadhyay AK; Saha PK; Garg S; Bhattacharya SK; Shimada T; Takeda T; Takeda Y; Nair GB
Epidemiol Infect; 1995 Feb; 114(1):65-70. PubMed ID: 7867744
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of non-O1/non-O139 Vibrio cholerae isolated from hospitalised patients in China.
Luo Y; Ye J; Jin D; Ding G; Zhang Z; Mei L; Octavia S; Lan R
BMC Microbiol; 2013 Mar; 13():52. PubMed ID: 23497008
[TBL] [Abstract][Full Text] [Related]
19. Surprising leads for a cholera toxin receptor-binding antagonist: crystallographic studies of CTB mutants.
Merritt EA; Sarfaty S; Chang TT; Palmer LM; Jobling MG; Holmes RK; Hol WG
Structure; 1995 Jun; 3(6):561-70. PubMed ID: 8590017
[TBL] [Abstract][Full Text] [Related]
20. Toxigenic Vibrio cholerae identified in estuaries of Tanzania using PCR techniques.
Dalusi L; Lyimo TJ; Lugomela C; Hosea KM; Sjöling S
FEMS Microbiol Lett; 2015 Mar; 362(5):. PubMed ID: 25743072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
